HSD17B1 and endometrial cancer: Variants in HSD17B1 have been examined for their relation to hormone levels, [13, 14] breast cancer [13, 15–24], endometriosis and endometrial cancer [13, 25–29], colorectal cancer [30, 31], and prostate cancer [32], with inconsistent results.